[go: up one dir, main page]

NO924991D0 - Nye 2-sakkarinylmetyl- og 4,5,6,7-tetrahydro-2-sakkarinyl-metylfosfater, -fosfonater og -fosfinater som er nyttige som inhibitorer for proteolytiske enzymer, samt preparaterog fremgangsmaate for anvendelse derav - Google Patents

Nye 2-sakkarinylmetyl- og 4,5,6,7-tetrahydro-2-sakkarinyl-metylfosfater, -fosfonater og -fosfinater som er nyttige som inhibitorer for proteolytiske enzymer, samt preparaterog fremgangsmaate for anvendelse derav

Info

Publication number
NO924991D0
NO924991D0 NO924991A NO924991A NO924991D0 NO 924991 D0 NO924991 D0 NO 924991D0 NO 924991 A NO924991 A NO 924991A NO 924991 A NO924991 A NO 924991A NO 924991 D0 NO924991 D0 NO 924991D0
Authority
NO
Norway
Prior art keywords
preparation
tetrahydro
phosphinates
phosphonates
useful
Prior art date
Application number
NO924991A
Other languages
English (en)
Other versions
NO303639B1 (no
NO924991L (no
Inventor
Ranjit Chimanial Desai
John Joseph Court
Dennis John Hlasta
Chakrapani Subramanyam
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of NO924991D0 publication Critical patent/NO924991D0/no
Publication of NO924991L publication Critical patent/NO924991L/no
Publication of NO303639B1 publication Critical patent/NO303639B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • C07F9/6541Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65744Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO924991A 1991-12-27 1992-12-23 Nye 2-sakkarinylmetyl- og 4,5,6,7-tetrahydro-2-sakkarinylmetylfosfater, -fosfonater og -fosfinater som er nyttige som inhibitorer for proteolytiske enzymer samt preparater og anvendelse derav NO303639B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/814,741 US5187173A (en) 1991-12-27 1991-12-27 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

Publications (3)

Publication Number Publication Date
NO924991D0 true NO924991D0 (no) 1992-12-23
NO924991L NO924991L (no) 1993-06-28
NO303639B1 NO303639B1 (no) 1998-08-10

Family

ID=25215883

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924991A NO303639B1 (no) 1991-12-27 1992-12-23 Nye 2-sakkarinylmetyl- og 4,5,6,7-tetrahydro-2-sakkarinylmetylfosfater, -fosfonater og -fosfinater som er nyttige som inhibitorer for proteolytiske enzymer samt preparater og anvendelse derav

Country Status (22)

Country Link
US (1) US5187173A (no)
EP (1) EP0549073B1 (no)
JP (1) JPH05271262A (no)
AT (1) ATE150755T1 (no)
AU (1) AU648938B2 (no)
CA (1) CA2085427A1 (no)
CZ (1) CZ371692A3 (no)
DE (1) DE69218568T2 (no)
DK (1) DK0549073T3 (no)
ES (1) ES2100274T3 (no)
FI (1) FI925875A7 (no)
GR (1) GR3023632T3 (no)
HU (1) HUT63630A (no)
IL (3) IL116601A (no)
MX (1) MX9207542A (no)
MY (1) MY106897A (no)
NO (1) NO303639B1 (no)
NZ (1) NZ245585A (no)
RU (1) RU2091377C1 (no)
SG (1) SG48310A1 (no)
SK (1) SK371692A3 (no)
TW (1) TW225538B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5296496A (en) * 1991-12-27 1994-03-22 Sterling Winthrop Inc. 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5541168A (en) * 1994-12-02 1996-07-30 Sterling Winthrop Inc. Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
IL163748A0 (en) * 2002-03-05 2005-12-18 Merck Frosst Canada Inc Cathepsin cysteine protease inhibitors
MXPA04008999A (es) * 2002-03-20 2004-12-07 Squibb Bristol Myers Co Profarmacos de fosfato de fluorooxindoles.
KR101447897B1 (ko) * 2005-03-21 2014-10-07 비로베이, 인코포레이티드 시스테인 단백질분해효소 억제제로서의 알파 케토아미드화합물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3002884A (en) * 1959-04-15 1961-10-03 Rohm & Haas Horticultural process with n-halomethyl-1,2-benzisothiazolin - 3 - one-1,1-dioxides for controlling fungus diseases
US3314960A (en) * 1964-08-25 1967-04-18 American Home Prod Benzisothiazol glutarimides
FR1451417A (fr) * 1965-07-15 1966-01-07 Roussel Uclaf Nouveaux esters d'acides cycliques et leur procédé de préparation
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4263393A (en) * 1979-09-06 1981-04-21 Eastman Kodak Company Novel electron donor precursors and photographic element containing them
US4350752A (en) * 1980-12-29 1982-09-21 Eastman Kodak Company Photographic elements and film units containing imidomethyl blocked photographic reagents
US4363865A (en) * 1981-03-04 1982-12-14 Eastman Kodak Company Imido methyl blocked photographic dyes and dye releasing compounds
US4410618A (en) * 1982-06-11 1983-10-18 Eastman Kodak Company Blocked photographic reagents
US4623645A (en) * 1983-04-18 1986-11-18 Merck & Co., Inc. Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents
US4547371A (en) * 1983-04-18 1985-10-15 Merck & Co., Inc. Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
US4659855A (en) * 1983-05-09 1987-04-21 Georgia Tech Research Corporation Aryl sulfonyl fluoride compounds
JPH026496A (ja) * 1988-06-27 1990-01-10 Ishihara Sangyo Kaisha Ltd 有機リン酸アミド系化合物、それらの製造方法及びそれらを含有する有害動物防除剤
WO1990013549A1 (en) * 1989-05-04 1990-11-15 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

Also Published As

Publication number Publication date
DE69218568T2 (de) 1997-11-13
IL116601A (en) 1997-04-15
NO303639B1 (no) 1998-08-10
GR3023632T3 (en) 1997-08-29
CZ371692A3 (en) 1994-04-13
FI925875L (fi) 1993-06-28
SK371692A3 (en) 1995-05-10
IL104229A0 (en) 1993-05-13
IL104229A (en) 1997-02-18
AU648938B2 (en) 1994-05-05
DE69218568D1 (de) 1997-04-30
JPH05271262A (ja) 1993-10-19
TW225538B (no) 1994-06-21
FI925875A7 (fi) 1993-06-28
IL116601A0 (en) 1996-03-31
RU2091377C1 (ru) 1997-09-27
US5187173A (en) 1993-02-16
AU2829492A (en) 1993-07-01
MY106897A (en) 1995-08-30
FI925875A0 (fi) 1992-12-23
ES2100274T3 (es) 1997-06-16
EP0549073A1 (en) 1993-06-30
NO924991L (no) 1993-06-28
EP0549073B1 (en) 1997-03-26
MX9207542A (es) 1993-06-01
CA2085427A1 (en) 1993-06-28
DK0549073T3 (da) 1997-10-06
HU9204123D0 (en) 1993-04-28
NZ245585A (en) 1995-05-26
SG48310A1 (en) 1998-04-17
ATE150755T1 (de) 1997-04-15
HUT63630A (en) 1993-09-28

Similar Documents

Publication Publication Date Title
FI885623A0 (fi) Menetelmä lääkeaineina käyttökelpoisten substituoitujen propaani-fosfiinihappoyhdisteiden valmistamiseksi
PH25769A (en) Certain cycloalkane-1,1-diphosphonic acids, derivatives thereof having the ability to treat diseases associated with abnormal calcium, phosphate metabolism
DE3582033D1 (de) Pharmazeutische zusammensetzungen, die geminale diphosphonate enthalten.
ES2080116T3 (es) Sal monosodica trihidratada cristalina del acido 4-amino-1-hidroxibutilideno-1,1-bisfosfonico, procedimiento para producirla y composiciones y uso de la misma.
AU2867089A (en) (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active ingredient
DK0544812T3 (da) Bisphosphonsyrederivater som anti-arthritiske midler
AR248140A1 (es) Composicion de 1, 4, 7, 10-tetraazaciclododecano como la fraccion macrolitica, o sales fisiologicamente aceptables del mismo y radionuclidos como agente terapeuticamente activo.
SE7706392L (sv) N-fosfonometylenmonoaminoalkanmono- och -polyfosfonsyror respektive n-fosfonometylendiaminoalkanpolyfosfonsyror samt sett for deras framstellning
NO924991L (no) Nye 2-sakkarinylmetyl- og 4,5,6,7-tetrahydro-2-sakkarinyl-metylfosfater, -fosfonater og -fosfinater som er nyttige som inhibitorer for proteolytiske enzymer, samt preparaterog fremgangsmaate for anvendelse derav
DK670387A (da) Nitrogenholdige, maettede, bicykliske cyclopentaringholdige diphosphonsyrer og farmaceutiske sammensaetninger omfattende disse
MX9307454A (es) Novedosos 2-sacarinilmetil fosfatos, fosfonatos y fosfinatos utiles como inhibidores de enzima proteolitica y composiciones y metodos de uso de los mismos.
RU92016280A (ru) Новые 2-сахаринилметил- и 4,5,6,7-тетрафлидро-2-сахаринил-метилфосфаты, -фосфонаты и -фосфинаты, используемые в качестве ингибиторов протеалитических ферментов, их композиции и способы использования
ES2163427T3 (es) Procedimiento para inhibir la formacion de depositos de oxalato.
NO176479C (no) Fremgangsmåte for fremstilling av aminometylenfosfonalkylfosfinatforbindelser
NO177675C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive P-substituerte propan-fosfinsyre forbindelser
DE3576649D1 (de) Prostaglandine zur behandlung von gehirnanoxie.
PT91001A (pt) Processo para a reparacao de composicoes contendo esteres fosfato uteis como lubrificantes
TH34790A (th) ไดฟอสฟีนที่ถูกแทนที่และกระบวนการสำหรับการเตรียมสารนั้น